Main Article Content

Authors

Srinivas Uppari

Dr. Shiv Brat Singh

Abstract

Pharmaceutical formulations are central to the success of drug therapy, as they directly influence the bioavailability, stability, and overall effectiveness of a medication. Ensuring that these formulations deliver the desired therapeutic effects while maintaining patient safety and compliance is an ongoing challenge in the pharmaceutical industry. Despite extensive research and development aimed at optimizing formulations for different drug classes, the real-world application of these formulations often presents unique obstacles. This review paper critically examines the various types of pharmaceutical formulations, such as oral, topical, injectable, and sustained-release systems, and evaluates the procedures employed to assess their performance in clinical settings. The focus is on the practical benefits and limitations of these formulations, taking into account factors such as patient preferences, ease of administration, and potential side effects. The paper also discusses the regulatory landscape, which is constantly evolving to address the complexities of modern drug delivery systems, and stresses the need for continuous post-market evaluation to ensure the long-term success and safety of pharmaceutical products. By understanding the challenges and opportunities presented by real-world use, the review aims to provide insights into improving therapeutic outcomes and ensuring that formulations remain effective in diverse clinical and consumer environments.

Downloads

Download data is not yet available.

Article Details

Section

Articles

References

  1. Ali, F., & Thakur, M. (2017). "Pharmaceutical Product Stability and Regulatory Concerns." Pharmaceutical Regulatory Affairs, 6(1), 45-51.
  2. Chen, Z., et al. (2020). "Impact of Pharmaceutical Excipients on Formulation Performance: A Review." International Journal of Pharmaceutics, 586(1), 120-128.
  3. EMA (2020). Regulatory Approaches for Pharmaceutical Formulations. European Medicines Agency.
  4. Evans, J., & Carlson, R. (2018). "Bioequivalence and Pharmaceutical Regulations: A Critical Review." Journal of Regulatory Science, 6(4), 75-84.
  5. FDA (2020). Guidelines for Pharmaceutical Development. U.S. Food and Drug Administration.
  6. Goh, H., et al. (2019). "Patient Adherence to Pharmaceutical Therapies: The Role of Formulation Design." Journal of Clinical Pharmacology, 59(6), 798-804.
  7. Huang, Y., & Zhang, R. (2020). "Patient-Centered Formulations: Addressing Challenges in Drug Adherence." Patient Preference and Adherence, 14, 1023-1030.
  8. Krogstad, D., et al. (2020). "Stability of Extended-Release Tablets in Diverse Patient Populations." Journal of Pharmaceutical Sciences, 109(4), 1234-1241.
  9. Kumar, A., & Srivastava, P. (2019). "Challenges in Pharmaceutical Formulations: A Global Perspective." Pharmaceutical Technology, 43(8), 65-72.
  10. Li, J., & Wang, H. (2019). "Innovative Approaches in Drug Formulation and Delivery Systems." European Journal of Pharmaceutical Sciences, 138, 105-112.
  11. Murphy, P., & Clark, R. (2019). "Advances in Injectable Pharmaceutical Formulations." Journal of Pharmaceutical Innovation, 14(3), 189-200.
  12. Nguyen, S., & Lee, W. (2018). "Pharmacokinetics and Bioavailability of Pharmaceutical Formulations: A Review." Asian Journal of Pharmaceutical Sciences, 13(3), 206-217.
  13. Patel, M., & Singh, R. (2020). "Evaluation of Bioequivalence in Generic Formulations." International Journal of Pharmaceutics, 580(2), 103-109.
  14. Shah, N., & Patel, V. (2018). "Pharmaceutical Formulation and Manufacturing Processes: Current Trends and Future Directions." European Pharmaceutical Review, 23(9), 42-48.
  15. Shukla, A., & Ghosh, M. (2020). "Modern Trends in the Development of Controlled-Release Formulations." Drug Development and Industrial Pharmacy, 46(7), 1015-1026.
  16. Singh, D., & Patil, H. (2019). "Stability Studies and Shelf Life of Pharmaceutical Products." Indian Journal of Pharmaceutical Sciences, 81(2), 153-158.
  17. Taylor, D., & Brown, M. (2020). "Regulatory and Quality Control Measures in Pharmaceutical Manufacturing." Pharmaceutical Quality Review, 9(2), 110-115.
  18. World Health Organization (2020). Guidelines for Stability Testing of Pharmaceutical Products. World Health Organization.
  19. Yang, L., et al. (2019). "Biosimilars: Regulatory Approaches and Market Opportunities." Biosimilars and Biologics Journal, 14(6), 134-140.
  20. Zhang, L., & Li, X. (2019). "Oral Drug Delivery: Formulation Challenges and Solutions." Journal of Controlled Release, 317, 182-192.